Sarepta Therapeutics (SRPT) Receivables Refunds (2023 - 2026)
Sarepta Therapeutics' quarterly Receivables Refunds came in at $14.0 million in Q1 2026, up 99.73% year-on-year from $7.0 million in Q1 2025, and down 10.07% quarter-over-quarter from $15.6 million in Q4 2025.
Sarepta Therapeutics has reported Receivables Refunds for 4 years, with the latest figure at $14.0 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables Refunds rose 99.73% year-over-year to $14.0 million; the trailing twelve-month figure through Mar 2026 stood at $14.0 million (up 99.73% YoY), and the FY2025 full-year result was $15.6 million, up 18.82% from the prior year.
- Receivables Refunds for Q1 2026 stood at $14.0 million, down from $15.6 million in the prior quarter.
- The five-year high for Receivables Refunds was $15.6 million in Q4 2025, with the low at $6.9 million in Q4 2023.
- Average Receivables Refunds over 4 years is $10.9 million, with a median of $11.4 million recorded in 2024.
- Year-over-year, Receivables Refunds decreased 13.92% in 2025 and soared 99.73% in 2026.
- Tracing SRPT's Receivables Refunds over 4 years: stood at $6.9 million in 2023, then surged by 91.37% to $13.1 million in 2024, then advanced by 18.82% to $15.6 million in 2025, then slipped by 10.07% to $14.0 million in 2026.
- The last three Receivables Refunds figures came in at $14.0 million (Q1 2026), $15.6 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 14.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.03 Mn |
| Dec 31, 2025 | 15.60 Mn |
| Sep 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 13.13 Mn |
| Sep 30, 2024 | 11.42 Mn |
| Jun 30, 2024 | 8.42 Mn |
| Dec 31, 2023 | 6.86 Mn |